Award Year / Program / Phase:
2011 / STTR / Phase I
Agency:
HHS
Research Institution:
CLEMSON UNIVERSITY
Award Amount:
$285,505.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): NUBAD, LLC is a drug discovery company devoted to identifying therapeutic agents that target nucleic acids. This project is designed to synthesize and characterize a novel class of fluorescently-labeled aminoglycosidesthat exhibit a dramatic change in…
More
Award Year / Program / Phase:
2012 / STTR / Phase I
Agency:
HHS
Research Institution:
CLEMSON UNIVERSITY
Award Amount:
$294,583.00
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): One of the challenges of research in infectious diseases is to find ways to use the increasing knowledge of the mechanisms underlying disease transformation and progression to develop novel therapeutic strategies for AIDS. Targeting specific RNA- protein…
More